Posts Tagged ‘sichenzia ross ference kesner’
Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $12 Million Credit Facility
Sichenzia Ross Ference Kesner LLP Represents A.G.P/ Alliance Global Partners (through Euro Pacific Capital) in $8 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc
$8,000,000
Public Offering of Common Stock
Represented A.G.P/ Alliance Global Partners
May 2018
Read MoreSichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement
MoneyOnMobile, Inc.
$5,000,000
Private Placement Offering
Series H Preferred Stock
February 2018
Read MoreSichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements
MoneyOnMobile, Inc.
$7,600,000
Private Placement Offering
Series F Preferred Stock
February 2018
Read MoreSichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $12.5 Million Registered Direct Offering
Vuzix Corporation
$12,500,000
Registered Direct Offering
Common Stock and Warrants
December 2017
Read MoreSichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.
Medical Transcript Billing, Corp.
$3,900,000
Series A Preferred Stock
Registered Public Offering
December 2017
Read MoreSichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement
Pareteum Corporation
$6,580,000
Common Stock and Warrants
Registered Public Offering
December 2017
Read MoreSichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $2.7 Million Registered Direct Offering
Precipio, Inc.
$2,700,000
Common Stock and Warrants
Represented Aegis Capital Corp. as Placement Agent
November 2017
Read MoreSichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering
Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.
